Will PT-141 darken my skin or freckles?
Yes, PT-141 can cause focal hyperpigmentation - dark patches on the face, gums, or breasts - especially with frequent use. This is because PT-141 acts on melanocortin receptors that also control skin pigment cells. In the Vyleesi trials, about 1% of patients reported this side effect. The risk appears higher with more frequent use and in people with darker baseline skin tone. New darker freckles or blotchy spots may fade after stopping but are not guaranteed to fully reverse. Talk to your provider about what is right for you.
- PT-141 binds the melanocortin-1 receptor (MC1R), which is the same receptor that triggers melanin production
- About 1% of phase 3 patients reported focal hyperpigmentation in the Vyleesi trials
- Risk appears higher in people with darker baseline skin tone and with more frequent use
- Pigmentation changes are typically focal (face, gums, breasts) rather than total-body tanning
- Reversibility is variable - some fade after stopping, some do not
Your guided peptide companion.
PRTCL walks beginners through their first peptide with confidence - guided reconstitution, syringe unit math from your own numbers, vial tracking, and answers to questions like this one. Built for first-timers, useful for everyone.
- · Guided walkthrough for your first dose
- · Your vial and your dose, converted into syringe units
- · Vial inventory and dose log tracking
- · A library where every claim cites its source
Free to start.